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TO THE EDITOR
The late cornified envelope (LCE) genes
are a group of highly homologous genes
located on chromosome 1 in the epider-
mal differentiation complex, which is a
1.6-Mb region on the human genome
containing a large number of genes
involved in epidermal differentiation.
The epidermal differentiation complex
contains a total of 18 LCE genes, divided
over six groups (Jackson et al., 2005).
Two genes of the LCE3 group, LCE3B
and LCE3C, are subject to copy number
variation caused by a commonly deleted
segment of 32 kb (de Cid et al., 2009).
Individuals can have copy number 0
(homozygous for the deletion), 1 (hetero-
zygous for the deletion), or 2 (homo-
zygous for the wild-type ancestral
haplotype). Deletion of LCE3B and
LCE3C (LCE3C_LCE3B-del) is a strong
and widely replicated risk factor for
psoriasis (de Cid et al., 2009; Zhang
et al., 2009; Huffmeier et al., 2010;
Riveira-Munoz et al., 2011). Recent
studies indicate that LCE3C_LCE3B-del
may also be a risk factor for other (auto)
immune diseases (Docampo et al., 2010,
2011; Lu et al., 2011), but it is not
associated with atopic dermatitis (Berg-
boer et al., 2010). LCE proteins are
expressed in a limited number of epithe-
lia (Marshall et al., 2001; Jackson et al.,
2005) and we have recently shown that
the genes of the LCE3 group, including
the psoriasis-associated LCE3B and
LCE3C genes, show distinct expression
patterns under inflammatory conditions
or upon skin injury (de Cid et al., 2009;
Bergboer et al., 2011). Out of all the
identified psoriasis-associated risk fac-
tors, only LCE3C_LCE3B-del and copy
number variation in the beta-defensin
cluster (Hollox et al., 2008) affect
expression of putative skin barrier pro-
teins. Although the observed odds ratios
(ORs) in various cohorts are smaller than
those published for HLA-Cw6 (current
notation HLA-C*06) (Liu et al., 2008;
Nair et al., 2009), the strongest known
psoriasis risk factor, LCE3C_LCE3B-del,
has a large population-attributable risk
(23%; de Cid et al., 2009). Both the
significant contribution to the genetic
basis of psoriasis and its plausible
biological function render LCE3C_
LCE3B-del an important risk factor that
is amenable to mechanistic studies.
In 1877, Heinrich Koebner described
the appearance of psoriatic lesions in the
uninvolved skin of psoriatic patients as a
consequence of trauma. Now, it is
known that patients with other derma-
tological conditions can koebnerize as
well (Weiss et al., 2002). Several causes
for this phenomenon are known, such as
trauma, allergic or drug reactions, and
therapeutics, although the pathogenesis
is not well understood (Weiss et al.,
2002). In previous studies it was shown
that on an average 25% of psoriasis
patients will koebnerize on external
stimulation of the skin (Weiss et al.,
2002). We hypothesized that the dele-
tion of the LCE3B and LCE3C genes
could lead to an inferior barrier function
or to an impaired repair function follow-
ing barrier disruption. This would make
the skin more susceptible to penetration
by microbial or other environmental
molecules, which could trigger innate
or adaptive immune responses. On the
basis of our hypothesis that the Koebner
reaction may be caused by breaching
the skin barrier and/or insufficient bar-
rier repair, we investigated a possible
association of the Koebner phenomenon
with LCE3C_LCE3B-del. In a Dutch
cohort of psoriasis patients who were
previously typed for LCE3C_LCE3B-del
(by PCR; de Cid et al., 2009) and HLA-
C*06:02 status (by PCR; de Cid et al.,
2009), we assessed their propensity to
koebnerize following skin injury. The
‘‘Commissie mensgebonden onderzoek
Arnhem-Nijmegen’’ approved this
study. Patients/parents of the patients
gave their informed consent. The inves-
tigations were carried out according to
the Declaration of Helsinki principles.
Adult patients were approached via
written questionnaires. In the case of
juvenile psoriasis patients we ap-
proached the parents by telephone. Both
the patients/parents and the interviewers
were unaware of the LCE3C_LCE3B-del
and HLA-C*06 status of the patients. We
assessed, on a 4-point scale, how often a
psoriasis plaque appeared after skin
damage of their non-involved skin:
never, rarely, often, or very common.
The individuals who responded with
‘‘often’’ or ‘‘very common’’ were con-
sidered as Koebner-positive patients and
the others as Koebner-negative patients.
We approached 259 patients, of whom
192 responded (response rate 74%). Of
these, 46 patients (24%) were Koebner
positive. This percentage is in line with
the previously reported data (Weiss
et al., 2002). We found similar figures
for adults (22%, n¼24) and children
(27%, n¼22). Table 1 shows an equal
distribution over the three LCE3B/C
genotypes for the Koebner-positive and
-negative groups. Logistic regression
analysis demonstrates that there is no
association between LCE3C_LCE3B-del
and the Koebner phenomenon in psor-
iasis patients (P¼ 0.835, OR 1.06, 95%
confidence interval (CI): 0.64–1.74). In
addition, for HLA-C*06 we did not
observe an association with the Koebner
phenomenon (P¼ 0.310, OR 1.43, 95%
CI: 0.72–2.82). This is in contrast with
a previously reported association bet-
ween Koebner effect and HLA-C*06 in
Icelandic psoriasis patients (Gudjonsson
Abbreviations: CI, confidence interval; LCE, late cornified envelope; LCE3C_LCE3B-del, deletion of the
LCE3B and LCE3C genes; OR, odds ratio
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et al., 2002). This discrepancy may
have several causes, such as the study
design (family-based vs. population-
based), ethnic background, inaccurate
reporting because of self-reported data,
or the lower statistical power of our
study (66%, input values were derived
from Gudjonsson et al. (2002); signifi-
cance level 0.05, OR 2.3, allele fre-
quency 0.28, dominant model).
Our results suggest that the Koebner
phenomenon in psoriasis is unlikely to
be dependent on the LCE3B/C geno-
type. Therefore, the biological role of
LCE3B and LCE3C deletion in develop-
ment and/or maintenance of psoriasis
remains to be explained.
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TO THE EDITOR
Ceramide is a family of lipid molecules
composed of a sphingoid base and
a fatty acid (FA) (Masukawa et al.,
2008). Ceramide constitutes a major
lipid component of cutaneous perme-
ability barrier, accounting forB50% of
the epidermal membrane structure
(Mizutani et al., 2009). Accordingly,
the alteration of ceramide in the derma-
toses with barrier dysfunction has
been a subject of intensive research
Table 1. No association between LCE3B/C copy number and









0 del/del 20 (43%) 66 (45%) 0.835 1.06 (0.64–1.74)
1 del/wt 21 (46%) 65 (45%)
2 wt/wt 5 (11%) 15 (10%)
Abbreviations: CI, confidence interval; del, deletion; OR, odds ratio; wt, wild type.
Abbreviations: AD, atopic dermatitis; CBF, cutaneous barrier function; FA, fatty acid; OXZ, 4-ethoxy-
methylene-2-phenyl-2-oxazolin-5-one; SC, stratum corneum; TEWL, trans-epidermal water loss
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